Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.

Palomero J, Galvao V, Creus I, Lostes J, Aylagas M, Marín-Bayo A, Rotxés M, Sanz M, Lozano-Rabella M, Garcia-Garijo A, Yuste-Estevanez A, Grases D, Díaz-Gómez J, González J, Navarro JF, Gartner JJ, Braña I, Villalobos X, Bayó-Puxan N, Jiménez J, Palazón AN, Muñoz S, Villacampa G, Piris-Giménez A, Barba P, Codinach M, Rodríguez L, Querol S, Muñoz-Couselo E, Tabernero J, Martín-Lluesma S, Gros A, Garralda E

Open source

DOI: 10.1016/j.iotech.2024.101030
Published: 2025 Mar
Container: Immuno-oncology technology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.iotech.2024.101030,
  title = {Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.},
  author = {Palomero J and Galvao V and Creus I and Lostes J and Aylagas M and Marín-Bayo A and Rotxés M and Sanz M and Lozano-Rabella M and Garcia-Garijo A and Yuste-Estevanez A and Grases D and Díaz-Gómez J and González J and Navarro JF and Gartner JJ and Braña I and Villalobos X and Bayó-Puxan N and Jiménez J and Palazón AN and Muñoz S and Villacampa G and Piris-Giménez A and Barba P and Codinach M and Rodríguez L and Querol S and Muñoz-Couselo E and Tabernero J and Martín-Lluesma S and Gros A and Garralda E},
  year = {2025},
  journal = {Immuno-oncology technology},
  doi = {10.1016/j.iotech.2024.101030},
  url = {https://doi.org/10.1016/j.iotech.2024.101030}
}

RIS

TY  - JOUR
TI  - Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.
AU  - Palomero J
AU  - Galvao V
AU  - Creus I
AU  - Lostes J
AU  - Aylagas M
AU  - Marín-Bayo A
AU  - Rotxés M
AU  - Sanz M
AU  - Lozano-Rabella M
AU  - Garcia-Garijo A
AU  - Yuste-Estevanez A
AU  - Grases D
AU  - Díaz-Gómez J
AU  - González J
AU  - Navarro JF
AU  - Gartner JJ
AU  - Braña I
AU  - Villalobos X
AU  - Bayó-Puxan N
AU  - Jiménez J
AU  - Palazón AN
AU  - Muñoz S
AU  - Villacampa G
AU  - Piris-Giménez A
AU  - Barba P
AU  - Codinach M
AU  - Rodríguez L
AU  - Querol S
AU  - Muñoz-Couselo E
AU  - Tabernero J
AU  - Martín-Lluesma S
AU  - Gros A
AU  - Garralda E
PY  - 2025
JO  - Immuno-oncology technology
DO  - 10.1016/j.iotech.2024.101030
UR  - https://doi.org/10.1016/j.iotech.2024.101030
ER  -

APA

J, P., V, G., I, C., J, L., M, A., A, M., M, R., M, S., M, L., A, G., A, Y., D, G., J, D., J, G., JF, N., JJ, G., I, B., X, V., N, B., J, J., AN, P., S, M., G, V., A, P., P, B., M, C., L, R., S, Q., E, M., J, T., S, M., A, G., & E, G. (2025). Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.. Immuno-oncology technology. https://doi.org/10.1016/j.iotech.2024.101030

Source records

pubmed · retrieved 2026-09-25T18:09:42.382Z